CRISPR Therapeutics AG (CRSP) Social Stream
CRISPR THERAPEUTICS AG (CRSP) Price Targets From Analysts
Use the tables below to see what analysts covering CRISPR THERAPEUTICS AG think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 17 | $220 | $100 | $161.357 | $71.14 | 126.82% |
| 2022-02-02 | 16 | $220 | $100 | $160.692 | $71.14 | 125.88% |
| 2022-02-04 | 17 | $220 | $100 | $158.846 | $71.14 | 123.29% |
| 2022-02-16 | 17 | $220 | $100 | $157.714 | $71.14 | 121.7% |
| 2022-02-17 | 17 | $220 | $64 | $154.785 | $71.14 | 117.58% |
| 2022-02-25 | 17 | $220 | $64 | $153 | $71.14 | 115.07% |
| 2022-05-09 | 16 | $220 | $64 | $152.461 | $71.14 | 114.31% |
| 2022-05-10 | 16 | $220 | $52 | $150.692 | $71.14 | 111.82% |
| 2022-05-12 | 16 | $220 | $52 | $140.714 | $71.14 | 97.8% |
| 2022-05-13 | 16 | $220 | $52 | $139.466 | $71.14 | 96.04% |
| 2022-05-16 | 16 | $220 | $52 | $137.8 | $71.14 | 93.7% |
| 2022-05-17 | 16 | $220 | $52 | $132.533 | $71.14 | 86.3% |
| 2022-05-23 | 17 | $220 | $52 | $128.2 | $71.14 | 80.21% |
| 2022-06-12 | 17 | $220 | $46 | $123.062 | $71.14 | 72.99% |
| 2022-06-13 | 17 | $220 | $46 | $123.375 | $71.14 | 73.43% |
| 2022-06-16 | 17 | $220 | $46 | $123.375 | $71.14 | 73.43% |
| 2022-06-22 | 17 | $220 | $46 | $121.882 | $71.14 | 71.33% |
| 2022-07-11 | 18 | $220 | $46 | $116.888 | $71.14 | 64.31% |
| 2022-08-02 | 17 | $220 | $46 | $118.555 | $71.14 | 66.65% |
| 2022-08-09 | 20 | $220 | $46 | $118.555 | $71.14 | 66.65% |
| 2022-08-10 | 20 | $220 | $46 | $117.411 | $71.14 | 65.04% |
| 2022-08-15 | 20 | $220 | $46 | $114.187 | $71.14 | 60.51% |
| 2022-09-28 | 19 | $220 | $46 | $114.312 | $71.14 | 60.69% |
| 2022-10-11 | 20 | $220 | $37 | $109.764 | $71.14 | 54.29% |
| 2022-11-02 | 20 | $220 | $37 | $107.833 | $71.14 | 51.58% |
| 2022-11-06 | 20 | $220 | $37 | $103.944 | $71.14 | 46.11% |
| 2022-11-07 | 20 | $220 | $37 | $104 | $71.14 | 46.19% |
| 2023-01-04 | 20 | $220 | $37 | $102.888 | $71.14 | 44.63% |
| 2023-01-12 | 21 | $220 | $37 | $101.421 | $71.14 | 42.57% |
| 2023-01-23 | 20 | $220 | $37 | $98.888 | $71.14 | 39% |
| 2023-02-08 | 21 | $220 | $37 | $97.368 | $71.14 | 36.87% |
| 2023-02-22 | 22 | $220 | $37 | $97.368 | $71.14 | 36.87% |
| 2023-02-23 | 22 | $220 | $37 | $93.108 | $71.14 | 30.88% |
| 2023-02-27 | 22 | $220 | $39 | $93.213 | $71.14 | 31.03% |
| 2023-03-03 | 22 | $220 | $39 | $92.897 | $71.14 | 30.58% |
| 2023-03-07 | 23 | $220 | $39 | $90.553 | $71.14 | 27.29% |
| 2023-03-27 | 22 | $220 | $39 | $90.153 | $71.14 | 26.73% |
| 2023-04-03 | 23 | $220 | $39 | $87.24 | $71.14 | 22.63% |
| 2023-05-08 | 24 | $220 | $39 | $86.548 | $71.14 | 21.66% |
| 2023-05-09 | 24 | $220 | $39 | $86.366 | $71.14 | 21.4% |
| 2023-05-12 | 24 | $220 | $42 | $85.59 | $71.14 | 20.31% |
| 2023-05-23 | 23 | $220 | $42 | $88.19 | $71.14 | 23.97% |
| 2023-06-09 | 24 | $220 | $42 | $87.727 | $71.14 | 23.32% |
| 2023-06-14 | 24 | $220 | $42 | $88.409 | $71.14 | 24.27% |
| 2023-08-08 | 22 | $220 | $42 | $89.25 | $71.14 | 25.46% |
| 2023-08-11 | 22 | $220 | $42 | $90.65 | $71.14 | 27.42% |
| 2023-08-16 | 23 | $220 | $43 | $90.7 | $71.14 | 27.5% |
| 2023-09-27 | 23 | $220 | $43 | $91.2 | $71.14 | 28.2% |
| 2023-11-06 | 23 | $220 | $43 | $91.2 | $71.14 | 28.2% |
| 2023-11-07 | 23 | $220 | $43 | $91.4 | $71.14 | 28.48% |
| 2023-11-10 | 23 | $220 | $43 | $90.85 | $71.14 | 27.71% |
| 2023-11-16 | 25 | $220 | $42 | $89.772 | $71.14 | 26.19% |
The Trend in the Analyst Price Target
Over the past 16 months, CRSP's average price target has gone down $28.78.
CRSP reports an average of 74.54% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-22 | 22 | 220 | 37 | 97.368 | 50.38 | 93.27% |
| 2023-03-07 | 22 | 220 | 39 | 90.553 | 47.84 | 89.28% |
| 2023-03-27 | 23 | 220 | 39 | 87.240 | 44.35 | 96.71% |
| 2023-08-11 | 22 | 220 | 43 | 90.700 | 49.65 | 82.68% |
| 2023-11-13 | 23 | 220 | 42 | 90.800 | 52.01 | 74.58% |
CRSP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.94 | 13 | 1 | 7 | 1 | 1 | 23 |
The Trend in the Broker Recommendations
Over the past 45 months, CRSP's average broker recommendation rating worsened by 0.29.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CRSP has a lower variance in analysts' estimates than -7239.72% of all US stocks.
- CRSP has a higher number of analysts covering the stock than 7041.22% of all US stocks.
- In the context of Pharmaceutical Products stocks, CRISPR THERAPEUTICS AG's average analyst price target is greater than 6622.78% of them.
- CRSP has a higher upside potential (average analyst target price relative to current price) than 5581.74% of stocks in the large market cap category.
Stocks similar to CRISPR THERAPEUTICS AG in the Pharmaceutical Products industry regarding analyst recommendations and price targets are QGEN, BLUE, and SGEN.
View All Top Stocks by Price Target
Is CRSP a Buy, Hold or Sell? See the POWR Ratings now!